Creating a New Kind of Doctor
We recruit and train physician leaders as comfortable taking on systemic challenges in health as caring for individual patients.
ARE YOU ONE?
Radical Collaboration. Real-World Impact.
Texas expertise fuels the discovery, delivery and diffusion of the next generation of preventions, diagnoses, treatments and cures.
LET'S GO
World Class. Close to Home.
We’re working to make person-centered, integrated care the standard in Central Texas and beyond.
Health Starts Here
More Information
GET CARE
Meet Dell Med
We’re rethinking the role of academic medicine in improving health — and doing so with a unique focus on our community.
ABOUT US
More Information
EXPLORE
Make an Appointment Give Faculty Students Alumni Directory

Michelle Lubetzky, M.D.

About

Michelle Lubetzky, M.D., is an associate professor of medicine in the Division of Nephrology at Dell Seton Medical Center with a focus on Kidney transplantation.

Before joining Dell Medical School she received her undergraduate degree in bioengineering at the University of Pennsylvania in 2001 and her M.D. at the Albert Einstein College of Medicine in 2005. She completed her residency and fellowships in nephrology and transplantation at the NewYork-Presbyterian Hospital/Weill Cornell Medical. Upon completion of fellowship, she joined the faculty at Einstein College of Medicine/Montefiore Medical Center as an assistant professor in the Division of Nephrology as a transplant nephrologist.

She spent five years at Einstein/Montefiore center where her research focused on the use of gene microarrays in kidney transplantation for both diagnosis and prognostication of acute rejection and transplant specific infections. Her clinical research during that time focused on clinical outcomes in transplantation. In 2017 she returned to Weill Cornell/NewYork-Presbyterian as an assistant professor of medicine in the Division of Nephrology and Transplantation. Her research at Weill Cornell focused on urinary gene expression for the diagnosis of acute rejection as well as novel techniques such as RNA Sequencing of the urine in acute rejection.

Lubetzky has practiced clinical transplant medicine for over 10 years, during which time she has authored over 40 peer-reviewed articles. She is active in the American Society of Transplantation Community of Practice group with a focus on the failing allograft and frailty.